BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 10687251)

  • 21. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
    Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
    Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention.
    de Winter RJ; Stroobants A; Koch KT; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; van Straalen JP; Fischer J; Tijssen JG; Piek JJ
    Am J Cardiol; 2004 Dec; 94(12):1481-5. PubMed ID: 15589000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum C-reactive protein at admission predicts in-hospital mortality in medical patients.
    Kompoti M; Drimis S; Papadaki A; Kotsomytis K; Poulopoulou C; Gianneli D; Voutsinas D
    Eur J Intern Med; 2008 Jun; 19(4):261-5. PubMed ID: 18471674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complicated acute myocardial infarction requiring mechanical ventilation in the intensive care unit: prognostic factors of clinical outcome in a series of 157 patients.
    Lesage A; Ramakers M; Daubin C; Verrier V; Beynier D; Charbonneau P; du Cheyron D
    Crit Care Med; 2004 Jan; 32(1):100-5. PubMed ID: 14707566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative evaluation of C-reactive protein as a short-term prognostic marker in severe unstable angina--a preliminary study.
    Bhagat S; Gaiha M; Sharma VK; Anuradha S
    J Assoc Physicians India; 2003 Apr; 51():349-54. PubMed ID: 12723647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes.
    Hartford M; Wiklund O; Mattsson Hultén L; Persson A; Karlsson T; Herlitz J; Caidahl K
    J Intern Med; 2007 Nov; 262(5):526-36. PubMed ID: 17908161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk.
    Kosiborod M; Inzucchi SE; Krumholz HM; Xiao L; Jones PG; Fiske S; Masoudi FA; Marso SP; Spertus JA
    Circulation; 2008 Feb; 117(8):1018-27. PubMed ID: 18268145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early assessment of heart rate variability is predictive of in-hospital death and major complications after acute myocardial infarction.
    Carpeggiani C; L'Abbate A; Landi P; Michelassi C; Raciti M; Macerata A; Emdin M
    Int J Cardiol; 2004 Sep; 96(3):361-8. PubMed ID: 15301888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction.
    Smit JJ; Ottervanger JP; Slingerland RJ; Kolkman JJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gosselink AT; de Boer MJ; Zijlstra F; van 't Hof AW;
    Am J Cardiol; 2008 Feb; 101(4):446-51. PubMed ID: 18312755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
    Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
    Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma CRP level predicts left ventricular function and exercise capacity in patients with acute myocardial infarction.
    Pandian S; Amuthan V; Sukumar P; Janarthanan RA; Murugan S; Palanichamy S; Subramaniam G; Annamalai M
    Indian Heart J; 2005; 57(1):54-7. PubMed ID: 15852896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of the mean platelet volume on the short-term prognosis of acute myocardial infarct].
    Pabón Osuna P; Nieto Ballesteros F; Moríñigo Muñoz JL; Sánchez Fernández PL; Arribas Jiménez A; Diego Domínguez M; Martín Luengo C
    Rev Esp Cardiol; 1998 Oct; 51(10):816-22. PubMed ID: 9834631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
    Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).
    Lim P; Moutereau S; Simon T; Gallet R; Probst V; Ferrieres J; Gueret P; Danchin N
    Am J Cardiol; 2013 Jan; 111(1):31-7. PubMed ID: 23062316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Early and late prognosis in acute myocardial infarct. A retrospective study in patients admitted to the coronary care unit in the past 10 years].
    De Martini M; Valentini R; Cesana B; Massari FM; Lettino M; Pupilella T; Ambrosini F; Eriano G; La Marchesina U; Lotto A
    G Ital Cardiol; 1990 Mar; 20(3):215-26. PubMed ID: 2344899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with C-reactive protein at the early stage of acute myocardial infarction in men.
    Piestrzeniewicz K; Łuczak K; Goch JH
    Cardiol J; 2009; 16(1):36-42. PubMed ID: 19130414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.